Financial Summary (All financials)
| In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 |
| Revenues | 0.1 | 0.1 | 0.1 | 12.2 | 3.4 |
| Revenue growth | 23.7% | -42.2% | -99.2% | 259.9% | |
| Cost of goods sold | 0.0 | 0.0 | -8.6 | 0.0 | 8.1 |
| Gross profit | 0.1 | 0.1 | 8.7 | 12.2 | -4.7 |
| Gross margin | 100.0% | 100.0% | 8500.0% | 100.0% | -137.6% |
| Research and development | 11.3 | 7.0 | 3.0 | 4.6 | |
| General and administrative | 6.6 | 6.5 | 5.6 | 4.6 | 4.5 |
| EBIT | -17.9 | -13.6 | -8.3 | 2.6 | -9.2 |
| EBIT margin | -24457.5% | -23044.1% | -8118.6% | 21.2% | -271.4% |
| Pre-tax income | -18.2 | -13.9 | -8.3 | 2.6 | -9.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -18.2 | -13.9 | -8.3 | 2.6 | -9.1 |
| Net margin | -24942.5% | -23528.8% | -8111.8% | 21.4% | -267.8% |
| |
| Diluted EPS | ($2.23) | ($3.23) | ($8.10) | $3.05 | ($12.94) |
| Shares outstanding (diluted) | 8.2 | 4.3 | 1.0 | 0.9 | 0.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|